StockData
Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (RARE) stock

RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$17.73+1.03 (+6.17%)

Close on Nov 18, 2026Market cap $1.75BP/E –Yield –

Ultragenyx Pharmaceutical market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ultragenyx Pharmaceutical's market cap was $1.65B on Nov 11, 2026, against $3.35B a year earlier. Over the last 5 years it ranged from $1.48B to $5.71B, with a median of $3.27B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.65B-25.8%
2025Dec 31, 2025$2.22B-42.9%
2024Dec 31, 2024$3.88B+12.5%
2023Dec 29, 2023$3.45B+6.3%
2022Dec 30, 2022$3.25B-43.2%
2021Dec 31, 2021$5.71B-32.1%
2020Dec 31, 2020$8.42B+241.3%
2019Dec 31, 2019$2.47B+12.3%
2018Dec 31, 2018$2.20B+11.5%
2017Dec 29, 2017$1.97B-30.0%
2016Dec 30, 2016$2.82B-35.3%
2015Dec 31, 2015$4.36B+211.7%
2014Dec 31, 2014$1.40B–

More Ultragenyx Pharmaceutical figures

See a number that looks wrong?